[Conservative treatment of breast cancer. Results after 10 years]. 1986

B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi

Between 1961 and 1975, 300 women with cancer of the breast (T1:72; T2:167; T3:61) were treated conservatively with radiotherapy alone (T3) or with partial or predominant radiotherapy combined with tumorectomy without axillary dissection (T1 or T2). The results, normalized at 10 years, confirmed that the survival rate (crude or NED) was exactly the same as with other conservative treatments or mutilating surgical treatments. Relapses were few (8%) in T1 cases and acceptable in T2 and T3 cases (13% and 18% respectively); in almost every patient they were amenable to surgery, with good local postoperative course. The prevalence of metastases was directly proportional to the size of the tumour; it was neither more nor less frequent than after radical surgery. Complications were rare and not very severe. Cosmetic results were either excellent (T1) or satisfactory (T2, T3). Finally, the proportions of breasts preserved at 10 years among patients alive and NED was very high, ranging from 96% (T1) to 91% (T2) and 87% (T3). These good results were associated with the possibility of high dosage additional endocurietherapy of the tumoral area with iridium 192, particularly in extensive forms where tumorectomy was cosmetically precluded. Since 1975, we have been using the conservative treatment in closer association with non mutilating surgery.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
January 1975, Annals of surgery,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
February 2009, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
December 1975, Annals of surgery,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
January 1989, Annales de chirurgie plastique et esthetique,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
September 2011, European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
December 1995, AJR. American journal of roentgenology,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
February 1988, The Australian and New Zealand journal of surgery,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
January 2000, International journal of radiation oncology, biology, physics,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
April 1995, Journal de chirurgie,
B Pierquin, and M Raynal, and Y Otmezguine, and J J Mazeron, and M Martin, and A Germain, and M Julien, and G Marinello, and J P Le Bourgeois, and E Calitchi
March 1991, Medicina clinica,
Copied contents to your clipboard!